Show
Sort by
-
Diagnosis and management of Aspergillus diseases : executive summary of the 2017 ESCMID-ECMM-ERS guideline
-
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
-
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
-
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma
-
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B